This post and conversation are about the molecularmechanisms triggered by microneedling, specifically its effects on inflammation, tissue remodeling, epithelial proliferation, differentiation, and collagen synthesis. The discussion highlights the potential benefits of microneedling for hairloss treatment.
PP405 is a promising new treatment for hairloss that activates dormant stem cells in hair follicles, potentially bypassing the effects of DHT. It is currently in phase 2 trials and could be available between 2027 and 2030, but it is not considered a definitive cure.
New potential hairloss treatment uses molecules from hairy moles to stimulate follicle growth. Topical solution requires less frequent application, like Botox injections a few times per year.
The conversation discusses whether dutasteride might cause less depression than finasteride for hairloss treatment, with some users suggesting it could due to different mechanisms of action or molecular size, while others express skepticism or share personal experiences with these medications.
PP405 is a promising molecule that may reactivate dormant hair follicles, potentially offering a new treatment for hairloss. It is in phase 2 trials, with possible availability between 2027 and 2030.